Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Arvin AM (1996) Varicella-zoster virus: overview and clinical manifestations. Semin Dermatol 15: 4–7
Asano Y, Yoshikawa T, Suga S et al. (1994) Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 93: 104–108
Beutner KR, Friedman DJ, Forszpaniak C et al. (1995) Valaciclovir compared with acyclovir for improved therapy of herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 37: 1546–1553
Blom I, Bäck O, Egelrud T et al. (1986) Longterm oral acyclovir treatment prevents recurrent genital herpes. Dermatologica 173: 220–223
Cassingham RJ (1971) Infectious mononucleosis; a review of the literature, including recent findigs on etiology. Oral Surg 31: 610–623
Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343: 481–492
Cruchley AT, Williams DM, Niedobitek G et al. (1997) Epstein-Barr virus: biology and disease. Oral Dis 3: S156–S163
*Feyrter F (1927) Wien Klin Wochenschr 40: 58
Fields BN (2001) Virology, 4th edn. Lippincott, Williams & Wilkins, Philadelphia
Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ et al. (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342: 635–645
Gross G, Schofer H, Wassilew S et al. (2003) Heres zoster guideline of the German Dermatology Society (DDG). J Clin Virol 26: 277–289
Hahn H, Falke D, Kaufmann SHE et al. (1999) Medizinische Mikrobiologie und Infektiologie, 3. Aufl. Springer, Berlin
*Hunt JR (1907) On herpetic inflammations of the geniculate ganglion. A new syndrome and its complications. J Nerv Ment Dis 34: 73–96
*Juliusberg F (1898) Über Pustulosis acuta varioformis. Arch Dermatol Syph 46: 21–28
*Kaposi M (1887) Pathologie und Therapie der Hautkrankheiten. Urban & Schwarzenberg, Wien, S 483
Kempf W, Lautenschlager S (2001) Infektionen mit dem Varizella-zoster-Virus. Hautarzt 52: 359–376
Koc Y, Miller KB, Schenkein DP et al. (2000) Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 6: 44–49
Lautenschlager S, Kempf W (2000) Herpes genitalis. Hautarzt 51: 964–983
Liesegang TJ (1984) The varicella-zoster virus: systemic and ocular features. J Am Acad Dermatol 11: 165–191
Ljungman P (2001) Prophylaxis against herpesvirus infections in transplant recipients. Drugs 61: 187–196
Lucas KG, Burton RL, Zimmermann SE et al. (1998) Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91: 3654–3661
Mahler V, Schuler G (2001) Therapie von Varizella-Zoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 1: Virustatische Agenzien. Hautarzt 52: 464–471
Mahler V, Schuler G (2001) Therapie von Varizella-Zoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 2: Hinweise zur Durchführung und Indikationen zur virustatischen Therapie. Hautarzt 52: 554–573
Modrow S, Falke D, Truyen U (2003) Molekulare Virologie, 2. Aufl. Spektrum Akademischer Verlag, Heidelberg
Pereira FA (1996) Herpes simplex: evolving concepts. J Am Acad Dermatol 35: 503–520
*Pfeiffer E (1889) Drüsenfieber. Jahrbuch Kinderheilkd Physische Erzieh 29: 257–264
*Pospischill D (1921) Über Klinik und Epidemiologie der Pertussis. Karger, Berlin
Rowbotham MC (1992) Treatment of postherpetic neuralgia. Semin Dermatol 3: 218–225
Sia IG, Patal R (2000) New strategies for prevention and therapy of cytomegalovirus infection and disease in solid organ transplant recipients. Clin Microbiol Rev 13: 83–121
Singh N (2000) Human herpesviruses-6,-7 and-8 in organ transplantat recipients. Clin Microbiol Infect 6: 453–459
Slomka MJ, Emery L, Munday PE et al. (1998) Comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 55: 177–183
Spruance SL (1992) The natural history of recurrent oral-facial herpes simplex virus infection. Semin Dermatol 3: 200–206
Tyring SK (1992) Natural history of varicella zoster virus. Semin Dermatol 3: 211–217
Tyring S, Belanger R, Bezwoda W et al. (2001) A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. Cancer Invest 19: 13–22
*Tzanck A (1947) Le cyto-diagnostic immediate en dermatologie. Ann Dermatol Venereol 7: 68–70
Ward KN (1998) Infections due to the herpesvirus group in immunocompromised patients. Curr Opin Infect Dis 11: 425–430
Wassilew SW (1984) Management of pain in herpes zoster. Semin Dermatol 3: 116–119
Whitley RJ, Roizman B (2001) Herpes simplex virus infections. Lancet 357:1513–1518
Wollenberg A, Zoch C, Wetzel et al (2003) Predisposing factors and clinical features of exzema herpeticum: A retrospective analysis of 100 cases. J Am Acad Dermatol 49:198–205
Wutzler P, Clercq E de, Wutke K et al. (1995) Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomised double-blind trial. J Med Virol 46: 252–25
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Stockfleth, E. (2005). Humane Herpesviren. In: Braun-Falco, O., Plewig, G., Wolff, H.H., Burgdorf, W.H.C., Landthaler, M. (eds) Dermatologie und Venerologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26624-0_6
Download citation
DOI: https://doi.org/10.1007/3-540-26624-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-40525-2
Online ISBN: 978-3-540-26624-2
eBook Packages: Medicine (German Language)